Logo image of BLZE

BACKBLAZE INC-A (BLZE) Stock Fundamental Analysis

NASDAQ:BLZE - Nasdaq - US05637B1052 - Common Stock - Currency: USD

5.3  +0.06 (+1.15%)

Fundamental Rating

3

Overall BLZE gets a fundamental rating of 3 out of 10. We evaluated BLZE against 82 industry peers in the IT Services industry. BLZE has a bad profitability rating. Also its financial health evaluation is rather negative. BLZE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BLZE has reported negative net income.
In the past year BLZE had a positive cash flow from operations.
BLZE had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BLZE reported negative operating cash flow in multiple years.
BLZE Yearly Net Income VS EBIT VS OCF VS FCFBLZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

BLZE's Return On Assets of -27.50% is on the low side compared to the rest of the industry. BLZE is outperformed by 85.37% of its industry peers.
BLZE has a worse Return On Equity (-60.18%) than 80.49% of its industry peers.
Industry RankSector Rank
ROA -27.5%
ROE -60.18%
ROIC N/A
ROA(3y)-35.95%
ROA(5y)-26.65%
ROE(3y)-90.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLZE Yearly ROA, ROE, ROICBLZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

BLZE's Gross Margin of 55.03% is fine compared to the rest of the industry. BLZE outperforms 75.61% of its industry peers.
In the last couple of years the Gross Margin of BLZE has grown nicely.
BLZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.43%
GM growth 5Y1.57%
BLZE Yearly Profit, Operating, Gross MarginsBLZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

BLZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
BLZE has more shares outstanding than it did 1 year ago.
BLZE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BLZE has been reduced compared to a year ago.
BLZE Yearly Shares OutstandingBLZE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BLZE Yearly Total Debt VS Total AssetsBLZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

BLZE has an Altman-Z score of 0.21. This is a bad value and indicates that BLZE is not financially healthy and even has some risk of bankruptcy.
BLZE's Altman-Z score of 0.21 is on the low side compared to the rest of the industry. BLZE is outperformed by 80.49% of its industry peers.
The Debt to FCF ratio of BLZE is 32.95, which is on the high side as it means it would take BLZE, 32.95 years of fcf income to pay off all of its debts.
BLZE has a Debt to FCF ratio (32.95) which is comparable to the rest of the industry.
BLZE has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.21, BLZE is doing good in the industry, outperforming 60.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 32.95
Altman-Z 0.21
ROIC/WACCN/A
WACC9.73%
BLZE Yearly LT Debt VS Equity VS FCFBLZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

BLZE has a Current Ratio of 1.09. This is a normal value and indicates that BLZE is financially healthy and should not expect problems in meeting its short term obligations.
BLZE has a Current ratio of 1.09. This is in the lower half of the industry: BLZE underperforms 73.17% of its industry peers.
A Quick Ratio of 1.09 indicates that BLZE should not have too much problems paying its short term obligations.
BLZE has a Quick ratio of 1.09. This is in the lower half of the industry: BLZE underperforms 71.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
BLZE Yearly Current Assets VS Current LiabilitesBLZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.71% over the past year.
BLZE shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.80%.
BLZE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.65% yearly.
EPS 1Y (TTM)21.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.43%
Revenue 1Y (TTM)21.8%
Revenue growth 3Y23.67%
Revenue growth 5Y25.65%
Sales Q2Q%15.5%

3.2 Future

BLZE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.82% yearly.
BLZE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.99% yearly.
EPS Next Y36.06%
EPS Next 2Y23.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.88%
Revenue Next 2Y13.99%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BLZE Yearly Revenue VS EstimatesBLZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
BLZE Yearly EPS VS EstimatesBLZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLZE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLZE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLZE Price Earnings VS Forward Price EarningsBLZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

BLZE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 295.24
EV/EBITDA N/A
BLZE Per share dataBLZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

BLZE's earnings are expected to grow with 23.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.82%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BLZE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BACKBLAZE INC-A

NASDAQ:BLZE (7/17/2025, 1:19:56 PM)

5.3

+0.06 (+1.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners42.1%
Inst Owner Change0%
Ins Owners3.83%
Ins Owner Change3.99%
Market Cap290.81M
Analysts84.29
Price Target11.79 (122.45%)
Short Float %3.58%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.35%
Min EPS beat(2)-23.41%
Max EPS beat(2)10.72%
EPS beat(4)2
Avg EPS beat(4)-5.56%
Min EPS beat(4)-23.41%
Max EPS beat(4)10.72%
EPS beat(8)5
Avg EPS beat(8)5.07%
EPS beat(12)5
Avg EPS beat(12)1.2%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.71%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-0.9%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-1.12%
Revenue beat(12)0
Avg Revenue beat(12)-1.06%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.22%
PT rev (3m)-1.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.88%
EPS NY rev (1m)2.27%
EPS NY rev (3m)2.27%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.2
P/FCF 295.24
P/OCF 20.72
P/B 3.74
P/tB 8.17
EV/EBITDA N/A
EPS(TTM)-1.01
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)0.02
FCFY0.34%
OCF(TTM)0.26
OCFY4.83%
SpS2.41
BVpS1.42
TBVpS0.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.5%
ROE -60.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.03%
FCFM 0.74%
ROA(3y)-35.95%
ROA(5y)-26.65%
ROE(3y)-90.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.43%
GM growth 5Y1.57%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 32.95
Debt/EBITDA N/A
Cap/Depr 44.71%
Cap/Sales 9.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 0.21
F-Score6
WACC9.73%
ROIC/WACCN/A
Cap/Depr(3y)70.19%
Cap/Depr(5y)63.54%
Cap/Sales(3y)16.57%
Cap/Sales(5y)15.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.43%
EPS Next Y36.06%
EPS Next 2Y23.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.8%
Revenue growth 3Y23.67%
Revenue growth 5Y25.65%
Sales Q2Q%15.5%
Revenue Next Year13.88%
Revenue Next 2Y13.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.65%
OCF growth 3Y52.59%
OCF growth 5Y-1.08%